Exact Mass: 497.1667562
Exact Mass Matches: 497.1667562
Found 85 metabolites which its exact mass value is equals to given mass value 497.1667562
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tebipenem Pivoxil
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor
Idarubicin
Idarubicin is only found in individuals that have used or taken this drug. It is an orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity. [PubChem]Idarubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Idarubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
(9S)-9-Acetyl-7-[(2R,4S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
Tebipenem pivoxil
Melphalan Flufenamide
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Idarubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
Cys Asp Phe Asn
C20H27N5O8S (497.15802620000005)
Cys Asp Asn Phe
C20H27N5O8S (497.15802620000005)
Cys Phe Asp Asn
C20H27N5O8S (497.15802620000005)
Cys Phe Asn Asp
C20H27N5O8S (497.15802620000005)
Cys Asn Asp Phe
C20H27N5O8S (497.15802620000005)
Cys Asn Phe Asp
C20H27N5O8S (497.15802620000005)
Asp Cys Phe Asn
C20H27N5O8S (497.15802620000005)
Asp Cys Asn Phe
C20H27N5O8S (497.15802620000005)
Asp Phe Cys Asn
C20H27N5O8S (497.15802620000005)
Asp Phe Asn Cys
C20H27N5O8S (497.15802620000005)
Asp Asn Cys Phe
C20H27N5O8S (497.15802620000005)
Asp Asn Phe Cys
C20H27N5O8S (497.15802620000005)
Asp Asn Ser Tyr
C20H27N5O10 (497.17578420000007)
Asp Asn Tyr Ser
C20H27N5O10 (497.17578420000007)
Asp Ser Asn Tyr
C20H27N5O10 (497.17578420000007)
Asp Ser Tyr Asn
C20H27N5O10 (497.17578420000007)
Asp Tyr Asn Ser
C20H27N5O10 (497.17578420000007)
Asp Tyr Ser Asn
C20H27N5O10 (497.17578420000007)
Phe Cys Asp Asn
C20H27N5O8S (497.15802620000005)
Phe Cys Asn Asp
C20H27N5O8S (497.15802620000005)
Phe Asp Cys Asn
C20H27N5O8S (497.15802620000005)
Phe Asp Asn Cys
C20H27N5O8S (497.15802620000005)
Phe Asn Cys Asp
C20H27N5O8S (497.15802620000005)
Phe Asn Asp Cys
C20H27N5O8S (497.15802620000005)
Asn Cys Asp Phe
C20H27N5O8S (497.15802620000005)
Asn Cys Phe Asp
C20H27N5O8S (497.15802620000005)
Asn Asp Cys Phe
C20H27N5O8S (497.15802620000005)
Asn Asp Phe Cys
C20H27N5O8S (497.15802620000005)
Asn Asp Ser Tyr
C20H27N5O10 (497.17578420000007)
Asn Asp Tyr Ser
C20H27N5O10 (497.17578420000007)
Asn Phe Cys Asp
C20H27N5O8S (497.15802620000005)
Asn Phe Asp Cys
C20H27N5O8S (497.15802620000005)
Asn Ser Asp Tyr
C20H27N5O10 (497.17578420000007)
Asn Ser Tyr Asp
C20H27N5O10 (497.17578420000007)
Asn Tyr Asp Ser
C20H27N5O10 (497.17578420000007)
Asn Tyr Ser Asp
C20H27N5O10 (497.17578420000007)
Ser Asp Asn Tyr
C20H27N5O10 (497.17578420000007)
Ser Asp Tyr Asn
C20H27N5O10 (497.17578420000007)
Ser Asn Asp Tyr
C20H27N5O10 (497.17578420000007)
Ser Asn Tyr Asp
C20H27N5O10 (497.17578420000007)
Ser Tyr Asp Asn
C20H27N5O10 (497.17578420000007)
Ser Tyr Asn Asp
C20H27N5O10 (497.17578420000007)
Tyr Asp Asn Ser
C20H27N5O10 (497.17578420000007)
Tyr Asp Ser Asn
C20H27N5O10 (497.17578420000007)
Tyr Asn Asp Ser
C20H27N5O10 (497.17578420000007)
Tyr Asn Ser Asp
C20H27N5O10 (497.17578420000007)
Tyr Ser Asp Asn
C20H27N5O10 (497.17578420000007)
Tyr Ser Asn Asp
C20H27N5O10 (497.17578420000007)
(7R,9R)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
4-[(2-hydroxy-3-nitrophenyl)-(5-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methyl]-5-methyl-2-phenyl-1H-pyrazol-3-one
Melphalan Flufenamide
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4,6,9-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
L-gammaGlu-S-[[1,7-Dioxo-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-3-yl]methyl]-L-Cys-Gly-OH
C20H27N5O8S (497.15802620000005)
(7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-1-methyl-4-oxo-6-(pyrrolidin-1-ylsulfonyl)-1,4-dihydroquinoline-3-carboxamide
C25H27N3O6S (497.1620482000001)
2-[4-[1-[1-[(4-Methylphenyl)sulfonylmethyl]-5-tetrazolyl]propyl]-1-piperazinyl]-1,3-benzothiazole
2-[(1R,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
(7R-cis)-9-Acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
(7R,9R)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(8s,10r)-8-acetyl-10-{[(2r,4r,5r,6r)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-1,8,11-trihydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]pentanediimidic acid
(1s,11s,13s,14r,15s,16s)-15-hydroxy-14-methoxy-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl 4-hydroxy-3-methoxybenzoate
5-chloro-2,6',13'-trihydroxy-4',4',7,7-tetramethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
C26H28ClN3O5 (497.17173880000007)
2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]pentanediimidic acid
(1s,11s,13s)-15-hydroxy-14-methoxy-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl 4-hydroxy-3-methoxybenzoate
8-acetyl-10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-1,8,11-trihydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(1's,3r,3's,6's,7'r)-5-chloro-2,6',13'-trihydroxy-4',4',7,7-tetramethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
C26H28ClN3O5 (497.17173880000007)